Skip to content
Tech News
clear
Topics: Today This Week This Month This Year

Review maps current drugs and pipeline candidates for treating MASH

A new review synthesizes the evolving treatment landscape for metabolic dysfunction-associated steatohepatitis (MASH), the liver disease formerly called NASH, drawing on updated epidemiological data, revised diagnostic terminology, and studies on liver fibrosis assessment. It outlines existing approaches alongside emerging therapies aimed at addressing the disease's metabolic, cardiovascular and cancer-related complications.

Researcher outlines a four-step method to manage scientific reading without AI shortcuts

A scientist who has logged 10,000 papers in a reference manager over 13 years describes moving from trying to read every paper closely to a selective, task-driven approach to the literature. The piece also warns that AI tools like ChatGPT, despite improved search and summarization, still risk producing uncritical or fabricated citations if used without careful reading.

AI models trained on gorilla, livestock data aim to flag disease spillover in Uganda

Conservation Through Public Health, working with the EU-Africa NESTLER project, gathered disease samples from cattle and poultry near Bwindi Impenetrable National Park and combined them with gorilla health monitoring records. The pooled data is being fed into AI models designed to predict zoonotic disease outbreaks before they spread among wildlife, livestock and people, shifting the group's approach from reactive response to proactive prevention.

Study finds newer Shingrix shingles vaccine linked to lower heart disease risk

A study of more than 70,000 people published in Nature Medicine found that those who received the current Shingrix shingles vaccine, rather than an older formulation, had a reduced risk of heart disease and heart failure. Researchers compared recipients of the two vaccine types rather than vaccinated versus unvaccinated people, a design meant to avoid the bias seen in earlier studies where healthier people were more likely to get vaccinated.

KAIST study finds excitatory neuron ERBB4 receptor drives Alzheimer's pathology in mice

Researchers at KAIST and the Institute for Basic Science, using APP/PS1 and 5×FAD mouse models along with human brain tissue from a Seoul National University Hospital bank, examined the role of the ERBB4 protein in excitatory neurons. Their experiments indicate that abnormal expression of ERBB4 in these neurons contributes to the progression of Alzheimer's disease-related brain changes.

Study finds CTE in nearly all 338 deceased NFL players' brains analyzed

Researchers examined brain tissue from 338 former NFL players who died recently and found that the vast majority showed signs of chronic traumatic encephalopathy, a degenerative brain disease linked to repeated head trauma. The new findings suggest the condition is more widespread among professional football players than previously estimated.

FDA clears WashU-derived PrecivityAD2 blood test for Alzheimer's diagnosis

The FDA has cleared PrecivityAD2, a blood test built on technology from Washington University School of Medicine, to help identify amyloid plaques linked to Alzheimer's disease. Developed by WashU spinoff C2N Diagnostics, the test uses high-resolution mass spectrometry to quantify biomarkers with over 90% accuracy, offering a less invasive option than spinal taps or brain imaging.

Today's top topics: openai apple anthropic artificial intelligence dario amodei samsung ai safety android authority beats 360 claude opus 5.5
View all today's topics →